Latest news with #Chandrasekaran
Economic Times
3 hours ago
- Business
- Economic Times
Tata Trusts put faith in N Chandrasekaran for another term to sustain growth
N Chandrasekaran has proved he has the calibre and excellent track record of delivering results. His leadership will ensure stability and growth Mumbai: Tata Trusts approved another five-year extension for N Chandrasekaran as chairman of Tata Sons in a unanimous decision, reinforcing leadership continuity at the group. The resolution, passed by all trustees of the key holding entities - Sir Ratan Tata Trust and Sir Dorabji Tata Trust - comes amid strategic deliberations to retain Tata Sons' status as a private entity and initiate discussions with Shapoorji Pallonji (SP) Group for a possible exit. The Tata Trusts resolution is expected to be endorsed by the Tata Sons board in due move reflects the Trusts' intent to maintain stability while navigating complex structural and shareholder transitions within the group. The Trusts own a controlling 66% in Tata Sons, group holding company. Stellar Performance An official close to the matter said the group's new businesses have a gestation period of at least five to seven years, with significant capital having been committed to them. 'Chandrasekaran has proved he has the calibre and an excellent track record of delivering results,' the person said. 'His leadership will ensure stability and growth.' The resolution was passed after discussions over the current performance and future plans of Tata group companies, people in the know said. 'The trustees are highly satisfied with the leadership and group growth demonstrated by Chandrasekaran in recent years,' said another highly placed official familiar with the matter. 'Chandrasekaran's experience and leadership abilities will help steer it through the critical phase of consolidating investments in new businesses and scaling them up. His steady hand will also be crucial in ensuring Tata Sons remains a privately held company, as envisioned by the Trusts.' Tata Sons and Tata Trusts did not comment. Among the challenges ahead is keeping Tata Sons unlisted, as sought by the Tata Trusts. Also, the chairman has to consider ways of giving minority investor SP Group an exit. The latter owns 18.37% of the unlisted holding Sons was classified as an Upper Layer NBFC (NBFC-UL) in September 2022, requiring it to list by September 2025. The company has, since, applied to RBI for deregistration and exemption from listing. It will also have to steer clear of taking on any debt in its balance was granted a second five-year term in February 2022. A TCS veteran, he joined the board of Tata Sons in October 2016 and was appointed chairman in January him at the helm, the group nearly doubled revenue and more than tripled net profit and market cap over the past five years, during which it spent Rs 5.5 lakh crore. The group's revenue from all listed and unlisted entities was Rs 15.34 lakh crore in FY25, with net profit at Rs 1.13 lakh crore and market cap at Rs 37.84 lakh crore.'Unlike typical stock market-driven companies, large multi-generational family-owned businesses across the globe don't have leadership only for few years but for a sufficiently long period so the leader can shape the generational evolution, and until the person has the trust of the owners and is capable of effectively leading the business, for which Chandrasekaran is a perfect fit,' said Sougata Ray, executive director of the Thomas Schmidheiny Centre for Family Enterprise at the Indian School of Business (ISB).
Time of India
4 hours ago
- Business
- Time of India
Tata Trusts put faith in N Chandrasekaran for another term to sustain growth
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel Mumbai: Tata Trusts approved another five-year extension for N Chandrasekaran as chairman of Tata Sons in a unanimous decision, reinforcing leadership continuity at the group. The resolution, passed by all trustees of the key holding entities - Sir Ratan Tata Trust and Sir Dorabji Tata Trust - comes amid strategic deliberations to retain Tata Sons' status as a private entity and initiate discussions with Shapoorji Pallonji (SP) Group for a possible exit. The Tata Trusts resolution is expected to be endorsed by the Tata Sons board in due move reflects the Trusts' intent to maintain stability while navigating complex structural and shareholder transitions within the group. The Trusts own a controlling 66% in Tata Sons, group holding official close to the matter said the group's new businesses have a gestation period of at least five to seven years, with significant capital having been committed to them. 'Chandrasekaran has proved he has the calibre and an excellent track record of delivering results,' the person said. 'His leadership will ensure stability and growth.'The resolution was passed after discussions over the current performance and future plans of Tata group companies, people in the know said. 'The trustees are highly satisfied with the leadership and group growth demonstrated by Chandrasekaran in recent years,' said another highly placed official familiar with the matter. 'Chandrasekaran's experience and leadership abilities will help steer it through the critical phase of consolidating investments in new businesses and scaling them up. His steady hand will also be crucial in ensuring Tata Sons remains a privately held company, as envisioned by the Trusts.'Tata Sons and Tata Trusts did not the challenges ahead is keeping Tata Sons unlisted, as sought by the Tata Trusts. Also, the chairman has to consider ways of giving minority investor SP Group an exit. The latter owns 18.37% of the unlisted holding Sons was classified as an Upper Layer NBFC (NBFC-UL) in September 2022, requiring it to list by September 2025. The company has, since, applied to RBI for deregistration and exemption from listing. It will also have to steer clear of taking on any debt in its balance was granted a second five-year term in February 2022. A TCS veteran, he joined the board of Tata Sons in October 2016 and was appointed chairman in January him at the helm, the group nearly doubled revenue and more than tripled net profit and market cap over the past five years, during which it spent Rs 5.5 lakh crore. The group's revenue from all listed and unlisted entities was Rs 15.34 lakh crore in FY25, with net profit at Rs 1.13 lakh crore and market cap at Rs 37.84 lakh crore.'Unlike typical stock market-driven companies, large multi-generational family-owned businesses across the globe don't have leadership only for few years but for a sufficiently long period so the leader can shape the generational evolution, and until the person has the trust of the owners and is capable of effectively leading the business, for which Chandrasekaran is a perfect fit,' said Sougata Ray, executive director of the Thomas Schmidheiny Centre for Family Enterprise at the Indian School of Business (ISB).
Time of India
17 hours ago
- Health
- Time of India
Discussing the #WeightofDiabetes with your Doctor
ET Spotlight Dr. Pankaj Aneja, M.B.B.S.,M.D.(Medicine), F.I.C.P., F.A.G.E., F.I.M.S.A., F.R.C.P. (Edinburgh), Senior Director, Department of Internal Medicine and Diabetology,Max Hospital (Shalimar Bagh and Pitampura), New Delhi Live Events Have you been told you have T2D or that you're at risk? Has your doctor talked about your BMI or weight? What does your daily routine look like: your meals, activities, sleep, and stress levels? Are you on any medications right now? What treatment options are available that address both diabetes and weight management and heart & other risks? Are there new treatments that can help with both my diabetes and weight? What are the possible side effects of the medications you're suggesting? How quickly might I see changes, and what does success look like to me? What lifestyle tweaks, like diet or exercise, could make a big difference? Can we set achievable goals that fit into my current lifestyle? ET Spotlight T2D and obesity are closely linked, and managing one without the other often falls short. Start the conversation by sharing your story, including your medical history, lifestyle, and goals, with your doctor. Ask smart questions about treatments, side effects, lifestyle changes, and what success looks like for you. Stay informed about new medications that can address both blood sugar and weight, and even protect your heart. Focus on progress, not perfection; small, consistent changes add up to lasting health improvements. Chandrasekaran P, Weiskirchen R. The Role of Obesity in Type 2 Diabetes Mellitus—An Overview. Int J Mol Sci. 2024;25(3):1882. Brown OI, Drozd M, McGowan H, Giannoudi M, Conning-Rowland M, Gierula J, Straw S, Wheatcroft SB, Bridge K, Roberts LD, Levelt E, Ajjan R, Griffin KJ, Bailey MA, Kearney MT, Cubbon RM. Relationship Among Diabetes, Obesity, and Cardiovascular Disease Phenotypes: A UK Biobank Cohort Study. Diabetes Care. 2023;46(8):1531-1540. Arneth B. Mechanisms of Insulin Resistance in Patients with Obesity. Endocrines. 2024;5(2):153-165. Townsend KL. One Nervous System: Critical Links Between Central and Peripheral Nervous System Health and Implications for Obesity and Diabetes. Diabetes. 2024;73(12):1967-1975. Korda, M. Semaglutide improves cardiovascular health independently of weight loss. Nat Cardiovasc Res. 2024;3:615. Maryam, Varghese, T.P., Tazneem, B. et al. Emerging Role of Weight-Loss Medications in the Management of Heart Failure: Current Evidence and Future Perspectives. Am J Cardiovasc Drugs.2025. Ambelu T, Teferi G. The impact of exercise modalities on blood glucose, blood pressure and body composition in patients with type 2 diabetes mellitus. BMC Sports Sci Med Rehabil. 2023;15:153. Naumann J, Biehler D, Lüty T, Sadaghiani C. Prevention and Therapy of Type 2 Diabetes—What Is the Potential of Daily Water Intake and Its Mineral Nutrients? Nutrients. 2017; 9(8):914. (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel If you're living with type 2 diabetes (T2D), obesity, or both, you're not alone. Millions are on this journey too. However, here's something many overlook: diabetes and obesity are often two sides of the same coin; closely linked, and when untreated, they can create a vicious cycle of declining good news? The first step is straightforward: initiate an honest and open conversation with your doctor. Ready to take that step? Let's explore how you can make that conversation truly impactful and set yourself on a path to better only one aspect without considering the other may not lead to comprehensive health outcomes. That's why a coordinated approach that considers both conditions can be the thing: diabetes and obesity often go hand in extra weight, especially around your belly, can make it tougher for your body to use insulin effectively, resulting in higher blood sugar time, this increased blood sugar level can harm your blood vessels, nerves, and important organs, but understanding this is the first step towards better just one without addressing the other is like fixing a leak but ignoring the broken pipe. That's why a holistic treatment plan, one that tackles both, is so you see your doctor, take a moment to think about a few things:Sharing honestly helps your doctor craft a personalised plan that truly fits your life, not just a number on a of your doctor as a supportive partner, not a judge. Sometimes, it can be tricky to figure out what questions to ask. Here are some ideas:Asking these questions shows you're truly engaged in your health and committed to your been a revolution in this space over the past few years. Treatment approaches may not only support blood sugar control, weight management but also provide cardiovascular health related benefits as why it's important to stay informed. The more you understand, the more confident you'll feel making decisions with your healthcare T2D and obesity isn't about striving for perfection. It's about celebrating small wins every day, whether that's a quick 10-minute walk after dinner, choosing water over soda, or beginning a new medication. Every little step makes a difference!You can be benefitted with a treatment plan that considers the entire picture, not only your sugar levels or your weight. Having a straightforward and honest conversation with your doctor can lead to feeling better, living healthier, and regaining control of your your next appointment, feel free to ask questions, share your goals, and speak openly. Remember, you're not alone in this journey; your doctor is a vital part of your team. Together, you can develop a personalised plan that genuinely suits your needs.
Time of India
a day ago
- Automotive
- Time of India
Tata Sons won't incur any debt unlike past takeovers
MUMBAI: In its biggest overseas deal and a strategic play aimed at expanding footprint in Europe, Tata Motors will buy Italian truck manufacturer Iveco for Euros 3.8 billion ($4.4 billion). Tired of too many ads? go ad free now Iveco will also be the biggest acquisition under Tata Group chairman N Chandrasekaran after Bhushan Steel and Air India. Chandrasekaran briefed the Tata Sons board on Wednesday about the deal. Tata Motors will launch an all-cash tender offer on Iveco's shares, subject to the sale of the Italian company's defence business, at 14.1 euros apiece. The defence business will be sold to Leonardo. Iveco's largest shareholder Exor will sell its 27.1% stake and 43.1% of voting rights to Tata Motors. Exor is owned by the Agnelli family, one of the founders of Fiat. The tender offer is subject to a minimum acceptance level of 80% of shares tendered. Iveco is active in more than 30 countries, including India, China, United States and Russia. It designs, manufactures, and sells trucks, buses and defence vehicles. It also offers financial products and services to dealers and customers. Tata Sons won't incur any debt unlike past takeovers Tata Motors and Iveco said, "The offer would bring together two businesses with highly complementary product portfolios and capabilities and with substantially no overlap in their industrial and geographic footprints." The combined group would have a significant global presence, with sales of over 5.4 lakh units per year and revenues of around 22 billion euros split across Europe (50%), India (35%) and the Americas (15%). Tata Motors' move follows the demerger of its commercial vehicle unit, which virtually has no manufacturing footprint in the European commercial vehicle industry. Tata Motors, which will route the acquisition through TML CV Holdings, incorporated under Dutch law, intends to delist Iveco from Euronext Milan stock exchange. Tired of too many ads? go ad free now Morgan Stanley Bank, Morgan Stanley Senior Funding and MUFG Bank have jointly underwritten the financing facilities of euros 3.8 billion for funding of the tender offer, Tata Motors said. Unlike previous major acquisitions, Tata Sons, the holding company of Tata Group, will neither incur debt nor provide financial guarantees for this transaction. This shift follows RBI regulations which prevent unregistered core investment companies from accessing public funds directly or indirectly. Tata Sons has already applied to relinquish its core investment company status. Previously, Tata Sons supported acquisitions of Tetley, Corus, VSNL (now Tata Communications) by raising debt on its books and offering letters of comfort to lenders on behalf of its subsidiaries. Chandrasekaran briefed the Tata Sons board about the deal on Wednesday. The 20-minute Tata Sons board meeting occurred without a pre-distributed agenda. According to industry observers, Tata Motors is facing storms with Jaguar Land Rover moving to electric vehicles, US tariffs affecting luxury models, and big spending needed to comply with new European rules. They believe the Iveco deal will increase borrowing as Tata Motors' current cash flow cannot adequately cover the M&A transaction.
India Today
a day ago
- Automotive
- India Today
Tata Motors to acquire Iveco in €3.8 billion deal, expanding global CV reach
In a landmark, Tata Motors has announced the acquisition of Italy's Iveco Group for 3.8 billion in an all-cash transaction. The deal will be executed through a voluntary tender offer made by TML CV Holdings PTE Ltd, a newly formed Dutch-incorporated entity entirely owned by Tata Motors. Upon completion, the combined entity will become one of the world's largest CV manufacturers, generating annual revenues of approximately 22 billion and sales exceeding 540,000 units per offer targets all issued common shares of Iveco Group, conditional upon the successful separation of its defence business by March 31, 2026. Shareholders are expected to receive an dividend of 5.5–6.0 per share from the sale of the defence unit, which has been valued at 1.7 billion. The offer price of 14.1 per share (excluding the dividend) represents a 34–41% premium, providing significant value to Iveco's deal has received unanimous approval from Iveco's Board of Directors, who have recommended the offer as being in the best interest of shareholders and stakeholders. Exor N.V., Iveco's largest shareholder with a 27.06% equity stake and 43.11% voting rights, has irrevocably committed to tender its shares and support the transaction. Following the acquisition, Iveco will be delisted from Euronext Milan and will continue to operate as a wholly owned subsidiary of Tata Motors, retaining its headquarters in Turin, Italy, and preserving its brands and industrial footprint. Strategically, the merger brings together highly complementary businesses with minimal geographic and product overlap. Tata's strong presence in India and Asia will be coupled with Iveco's established operations in Europe and the Americas. The combined entity's revenues will be split roughly 50% from Europe, 35% from India, and 15% from the Americas, along with a growing presence in Asia and Africa. Together, the two companies aim to leverage their strengths in product development, powertrain capabilities, and zero-emission mobility ensure operational continuity and employee stability, Tata Motors has committed to a robust set of non-financial covenants, valid for two years post-settlement. These include no job losses or plant closures directly resulting from the merger, preservation of employee rights and benefits, and continued support for Iveco's strategic roadmap and capital expenditure plans. The governance structure will also remain intact, with two independent directors appointed to oversee compliance with the agreed Motors has secured full financing for the deal from Morgan Stanley and MUFG, ensuring high certainty of completion. Advisors on the transaction include Goldman Sachs (for Iveco), Morgan Stanley (for Tata Motors), and law firms Clifford Chance, De Brauw Blackstone Westbroek, and PedersoliGattai, among Chandrasekaran, Chairman of Tata Motors, called the acquisition a 'logical next step' after the recent demerger of the CV business, enabling the company to compete globally with dual strategic bases in India and Europe. Iveco Chair Suzanne Heywood echoed this sentiment, emphasising the alignment of the two companies' visions for sustainable mobility and long-term industrial acquisition positions Tata Motors and Iveco Group to lead in the future of commercial mobility, with enhanced scale, a diversified global footprint, and a shared focus on innovation, electrification, and sustainability. Subject to regulatory approvals, the transaction is expected to close by April, to Auto Today Magazine- Ends
